Maine Molecular Quality Controls releases the Birlinn CoV2-Flu-RSV Control Panel M509
Maine Molecular Quality Controls has released the Birlinn CoV2-Flu-RSV Control Panel M509, intended for use as a quality control to monitor the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of target gene segments in Influenza A, Influenza B, Respiratory Syncytial Virus A/B and SARS-CoV-2.
Equipping healthcare professionals with a single integrated combination test is beneficial in settings where timely clinical decisions are needed or where central laboratory testing is difficult to access.
This multiplex 5-in-1 control panel for respiratory infections testing ensures quick, comprehensive confidence in test results, and helps clinicians provide accurate diagnostics to support fast treatment decisions and deliver optimal care.
This control has been tested on over a dozen different assay platforms. Contact Maine Molecular Quality Controls to ask about your specific assay.
